uniQure is focused on the research and early development of human gene-based therapies. It develops treatment and platform for patients suffering from genetic and other devastating diseases. The Company's products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases.
Market capitalization (23-Sept-2021)
Closing stock price (23-Sept-2021)
UniQure has 2.34k Twitter Followers. The number of followers has increased 0.7% month over month and increased 4.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was UniQure founded?
UniQure was founded in 1998.
Who are UniQure key executives?
UniQure's key executives are Jack Kaye, Jonathan Garen and Paula Soteropoulos.
How many employees does UniQure have?
UniQure has 332 employees.
Who are UniQure competitors?
Competitors of UniQure include Synchronicity Pharma, Marsala Biotech and Neuren Pharmaceuticals.
Where is UniQure headquarters?
UniQure headquarters is located at Paasheuvelweg 25a, Amsterdam.
Where are UniQure offices?
UniQure has an office in Amsterdam.
How many offices does UniQure have?
UniQure has 1 office.
Receive alerts for 300+ data fields across thousands of companies